304 related articles for article (PubMed ID: 33847259)
1. Endocrine-Disrupting Chemicals: Introduction to the Theme.
Lisco G; Giagulli VA; Iovino M; Guastamacchia E; Pergola G; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2022 Aug; 22(7):677-685. PubMed ID: 33847259
[TBL] [Abstract][Full Text] [Related]
2. Bone Disruption and Environmental Pollutants.
Giannattasio R; Lisco G; Giagulli VA; Settembrini S; De Pergola G; Guastamacchia E; Lombardi G; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2022 Aug; 22(7):704-715. PubMed ID: 33461478
[TBL] [Abstract][Full Text] [Related]
3. The effect of endocrine-disrupting chemicals on placental development.
Yan Y; Guo F; Liu K; Ding R; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1059854. PubMed ID: 36896182
[TBL] [Abstract][Full Text] [Related]
4. Endocrine Disrupting Chemicals' Effects in Children: What We Know and What We Need to Learn?
Predieri B; Iughetti L; Bernasconi S; Street ME
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233201
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disrupting chemicals and bone.
Turan S
Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101495. PubMed ID: 33618984
[TBL] [Abstract][Full Text] [Related]
6. Endocrine disruptors and endometriosis.
Dutta S; Banu SK; Arosh JA
Reprod Toxicol; 2023 Jan; 115():56-73. PubMed ID: 36436816
[TBL] [Abstract][Full Text] [Related]
7. Persistent environmental endocrine-disrupting chemicals in ovarian follicular fluid and
Björvang RD; Damdimopoulou P
Ups J Med Sci; 2020 May; 125(2):85-94. PubMed ID: 32093529
[TBL] [Abstract][Full Text] [Related]
8. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
Yilmaz B; Terekeci H; Sandal S; Kelestimur F
Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
[TBL] [Abstract][Full Text] [Related]
9. Placenta Disrupted: Endocrine Disrupting Chemicals and Pregnancy.
Gingrich J; Ticiani E; Veiga-Lopez A
Trends Endocrinol Metab; 2020 Jul; 31(7):508-524. PubMed ID: 32249015
[TBL] [Abstract][Full Text] [Related]
10. Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System.
Guarnotta V; Amodei R; Frasca F; Aversa A; Giordano C
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628520
[TBL] [Abstract][Full Text] [Related]
11. Transgenerational epigenetic effects from male exposure to endocrine-disrupting compounds: a systematic review on research in mammals.
Van Cauwenbergh O; Di Serafino A; Tytgat J; Soubry A
Clin Epigenetics; 2020 May; 12(1):65. PubMed ID: 32398147
[TBL] [Abstract][Full Text] [Related]
12. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
[TBL] [Abstract][Full Text] [Related]
13. Review on crosstalk and common mechanisms of endocrine disruptors: Scaffolding to improve PBPK/PD model of EDC mixture.
Sharma RP; Schuhmacher M; Kumar V
Environ Int; 2017 Feb; 99():1-14. PubMed ID: 27697394
[TBL] [Abstract][Full Text] [Related]
14. Pregnant Women and Endocrine Disruptors: Role of P2X7 Receptor and Mitochondrial Alterations in Placental Cell Disorders.
Fouyet S; Olivier E; Leproux P; Dutot M; Rat P
Cells; 2022 Jan; 11(3):. PubMed ID: 35159304
[TBL] [Abstract][Full Text] [Related]
15. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
[TBL] [Abstract][Full Text] [Related]
16. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
[TBL] [Abstract][Full Text] [Related]
17. Endocrine-Disrupting Chemicals and Disease Endpoints.
Ahn C; Jeung EB
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982431
[TBL] [Abstract][Full Text] [Related]
18. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
Dogan S; Simsek T
Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
[TBL] [Abstract][Full Text] [Related]
19. Endocrine disrupting chemicals and disease susceptibility.
Schug TT; Janesick A; Blumberg B; Heindel JJ
J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):204-15. PubMed ID: 21899826
[TBL] [Abstract][Full Text] [Related]
20. Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship.
Modica R; Benevento E; Colao A
J Endocrinol Invest; 2023 Apr; 46(4):667-677. PubMed ID: 36526827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
